Bridgewater Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,393
Closed -$207K 790
2024
Q4
$207K Sell
9,393
-13,829
-60% -$305K ﹤0.01% 677
2024
Q3
$418K Buy
23,222
+1,144
+5% +$20.6K ﹤0.01% 705
2024
Q2
$359K Sell
22,078
-24,583
-53% -$399K ﹤0.01% 799
2024
Q1
$658K Sell
46,661
-26,413
-36% -$373K ﹤0.01% 602
2023
Q4
$763K Sell
73,074
-121,451
-62% -$1.27M ﹤0.01% 667
2023
Q3
$1.98M Sell
194,525
-37,985
-16% -$387K 0.01% 502
2023
Q2
$1.75M Sell
232,510
-10,137
-4% -$76.3K 0.01% 488
2023
Q1
$2.15M Sell
242,647
-66,770
-22% -$591K 0.01% 451
2022
Q4
$2.82M Sell
309,417
-134,841
-30% -$1.23M 0.02% 470
2022
Q3
$3.59M Sell
444,258
-40,785
-8% -$329K 0.02% 450
2022
Q2
$3.65M Sell
485,043
-56,471
-10% -$425K 0.02% 569
2022
Q1
$5.09M Buy
541,514
+21,895
+4% +$206K 0.02% 465
2021
Q4
$4.16M Buy
519,619
+244,402
+89% +$1.96M 0.02% 335
2021
Q3
$2.68M Buy
275,217
+33,548
+14% +$327K 0.01% 390
2021
Q2
$2.39M Buy
+241,669
New +$2.39M 0.02% 461
2018
Q4
Sell
-23,600
Closed -$508K 513
2018
Q3
$508K Buy
23,600
+2,400
+11% +$51.7K 0.01% 279
2018
Q2
$516K Hold
21,200
0.01% 360
2018
Q1
$362K Sell
21,200
-6,500
-23% -$111K ﹤0.01% 415
2017
Q4
$525K Hold
27,700
﹤0.01% 224
2017
Q3
$488K Hold
27,700
﹤0.01% 255
2017
Q2
$920K Buy
27,700
+3,000
+12% +$99.6K 0.01% 214
2017
Q1
$793K Hold
24,700
0.01% 202
2016
Q4
$895K Hold
24,700
0.01% 233
2016
Q3
$1.14M Hold
24,700
0.01% 217
2016
Q2
$1.24M Hold
24,700
0.02% 226
2016
Q1
$1.32M Buy
24,700
+600
+2% +$32.1K 0.02% 210
2015
Q4
$1.58M Buy
+24,100
New +$1.58M 0.02% 199